160 related articles for article (PubMed ID: 38374399)
1. VAV2 orchestrates the interplay between regenerative proliferation and ribogenesis in both keratinocytes and oral squamous cell carcinoma.
Fernández-Parejo N; Lorenzo-Martín LF; García-Pedrero JM; Rodrigo JP; Dosil M; Bustelo XR
Sci Rep; 2024 Feb; 14(1):4060. PubMed ID: 38374399
[TBL] [Abstract][Full Text] [Related]
2. VAV2 signaling promotes regenerative proliferation in both cutaneous and head and neck squamous cell carcinoma.
Lorenzo-Martín LF; Fernández-Parejo N; Menacho-Márquez M; Rodríguez-Fdez S; Robles-Valero J; Zumalave S; Fabbiano S; Pascual G; García-Pedrero JM; Abad A; García-Macías MC; González N; Lorenzano-Menna P; Pavón MA; González-Sarmiento R; Segrelles C; Paramio JM; Tubío JMC; Rodrigo JP; Benitah SA; Cuadrado M; Bustelo XR
Nat Commun; 2020 Sep; 11(1):4788. PubMed ID: 32963234
[TBL] [Abstract][Full Text] [Related]
3. Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperplastic Keratinocytes and Head and Neck Cancer.
Lorenzo-Martín LF; Menacho-Márquez M; Bustelo XR
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899210
[TBL] [Abstract][Full Text] [Related]
4. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
5. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.
Lai SY; Ziober AF; Lee MN; Cohen NA; Falls EM; Ziober BL
Oral Oncol; 2008 Jul; 44(7):683-8. PubMed ID: 17996485
[TBL] [Abstract][Full Text] [Related]
6. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
7. CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis.
Mohapatra P; Mohanty S; Ansari SA; Shriwas O; Ghosh A; Rath R; Majumdar SKD; Swain RK; Raghav SK; Dash R
FASEB J; 2022 Oct; 36(10):e22566. PubMed ID: 36165231
[TBL] [Abstract][Full Text] [Related]
8. Vav2 is an activator of Cdc42, Rac1, and RhoA.
Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
[TBL] [Abstract][Full Text] [Related]
9. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation.
Hasegawa K; Fujii S; Matsumoto S; Tajiri Y; Kikuchi A; Kiyoshima T
J Pathol; 2021 Jan; 253(1):80-93. PubMed ID: 32985688
[TBL] [Abstract][Full Text] [Related]
10. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor.
Lorenzo-Martín LF; Rodríguez-Fdez S; Fabbiano S; Abad A; García-Macías MC; Dosil M; Cuadrado M; Robles-Valero J; Bustelo XR
Oncogene; 2020 Jul; 39(28):5098-5111. PubMed ID: 32528129
[TBL] [Abstract][Full Text] [Related]
11. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
Liu BP; Burridge K
Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation.
Yap LF; Jenei V; Robinson CM; Moutasim K; Benn TM; Threadgold SP; Lopes V; Wei W; Thomas GJ; Paterson IC
Oncogene; 2009 Jul; 28(27):2524-34. PubMed ID: 19448673
[TBL] [Abstract][Full Text] [Related]
13. VAV2, a guanine nucleotide exchange factor for Rac1, regulates glucose-stimulated insulin secretion in pancreatic beta cells.
Veluthakal R; Tunduguru R; Arora DK; Sidarala V; Syeda K; Vlaar CP; Thurmond DC; Kowluru A
Diabetologia; 2015 Nov; 58(11):2573-81. PubMed ID: 26224100
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for Rho versus Rac/Cdc42 GTPases downstream of Vav2 in regulating mammary epithelial acinar architecture.
Duan L; Chen G; Virmani S; Ying G; Raja SM; Chung BM; Rainey MA; Dimri M; Ortega-Cava CF; Zhao X; Clubb RJ; Tu C; Reddi AL; Naramura M; Band V; Band H
J Biol Chem; 2010 Jan; 285(2):1555-68. PubMed ID: 19826000
[TBL] [Abstract][Full Text] [Related]
15. A YAP/TAZ-Regulated Molecular Signature Is Associated with Oral Squamous Cell Carcinoma.
Hiemer SE; Zhang L; Kartha VK; Packer TS; Almershed M; Noonan V; Kukuruzinska M; Bais MV; Monti S; Varelas X
Mol Cancer Res; 2015 Jun; 13(6):957-68. PubMed ID: 25794680
[TBL] [Abstract][Full Text] [Related]
16. The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells.
Sauzeau V; Sevilla MA; Montero MJ; Bustelo XR
J Clin Invest; 2010 Jan; 120(1):315-30. PubMed ID: 20038798
[TBL] [Abstract][Full Text] [Related]
17. Paxillin kinase linker (PKL) regulates Vav2 signaling during cell spreading and migration.
Jones MC; Machida K; Mayer BJ; Turner CE
Mol Biol Cell; 2013 Jun; 24(12):1882-94. PubMed ID: 23615439
[TBL] [Abstract][Full Text] [Related]
18. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
[TBL] [Abstract][Full Text] [Related]
19. Collagen phagocytosis is regulated by the guanine nucleotide exchange factor Vav2.
Arora PD; Marignani PA; McCulloch CA
Am J Physiol Cell Physiol; 2008 Jul; 295(1):C130-7. PubMed ID: 18434624
[TBL] [Abstract][Full Text] [Related]
20. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
